A company started by former executives from Kite Pharma has raised $120 million to develop the next generation of CAR-T therapies.
{iframe}https://medcitynews.com/2018/09/allogene-raises-120m-for-off-the-shelf-car-t-development/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=65772154&_hsenc=p2ANqtz-8OJMFFBYUPX0Bg6v9olQdRK3CagxISNIq3ydBbU5gxbjKfSJrXX8ouudWdFNZMEHw9Um3N6LTREV2MdHa4OmU4Wvm8MA&_hsmi=65772154{/iframe}